Mark Miller is the founder of Biosynthetic Technologies. Biosynthetic Technologies has raised $8M in total funding. Latest round: Series A.
Mark Miller was the CEO of Biosynthetic Technologies, an Indianapolis-based biotechnology company that produces biobased synthetic compounds from organic fatty acids. The company's products are used in various applications including lubricants, automotive, marine, pharma, and personal care.
Full founder directory · Investor directory · Company funding database · Fundraising library